Cost of hypertension medications: is it a barrier to hypertension control?
Surveys conducted in the 1970s indicated that the cost of antihypertensive drugs was seldom a barrier to the control of hypertension. More recent surveys of both patients and physicians, however, have revealed that the cost of these medications is a growing problem. Physicians have more options than were available a decade ago, and many of the newer drugs are expensive. It is important that physicians consider the cost when selecting a course of treatment for their patients.
Roccella
E J
EJ
National High Blood Pressure Education Program, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D011307:Drug Prescriptions / Q000191:economics*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged
D000959:Antihypertensive Agents